Medicenna Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Year	Current	2022	2021	2020	2019
Market Capitalization	105	44	71	206	-
Market Cap Growth	-48.03%	-38.36%	-65.51%	-	-
Enterprise Value	76	19	55	174	-26
PE Ratio	-	-6.02	-3.97	-14.79	-
PB Ratio	3.92	2.05	4.30	6.70	-
P/FCF Ratio	-3.23	-4.78	-3.80	-16.70	-
P/OCF Ratio	-3.23	-4.78	-3.80	-16.70	-
EV/EBITDA Ratio	-1.71	-2.68	-3.07	-12.49	4.55
EV/EBIT Ratio	-1.71	-2.68	-3.06	-12.46	4.55
EV/FCF Ratio	-1.09	-2.13	-2.93	-14.07	6.95
Debt / Equity Ratio	-	-	-	0.00	0.00
Debt / EBITDA Ratio	-	-	-	0.00	-0.01
Debt / FCF Ratio	-	-	-	0.00	-0.01
Quick Ratio	9.42	9.07	8.33	9.93	20.80
Current Ratio	9.74	9.57	8.92	10.26	20.86
Return on Equity (ROE)	-28.40%	-35.10%	-88.90%	-46.90%	-42.70%
Return on Assets (ROA)	-23.50%	-29.30%	-77.20%	-44.00%	-38.30%
Return on Capital (ROIC)	-61.09%	-55.29%	-107.86%	-45.56%	-22.77%
Earnings Yield	-8.30%	-16.61%	-25.19%	-6.76%	-
FCF Yield	-13.11%	-20.92%	-26.32%	-5.99%	-
Buyback Yield / Dilution	-24.06%	-19.25%	-9.31%	-55.68%	-24.25%
Total Shareholder Return	-24.06%	-19.25%	-9.31%	-55.68%	-24.25%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).